secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001213900-25-122240
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD shareholders approve all proposals including share authorization increase to 640M
--------------------------------------------------------------------------------

- Four director nominees elected: Thompson, Collins, Naughton, Roberts; each received >5.1M for votes.
- Advisory say-on-pay approved: 5.16M for, 81.6K against, 8.3K abstain.
- Advisory vote on frequency: 1-year chosen (5.18M votes); board adopts annual advisory vote.
- Ratification of Berkowitz Pollack Brant as FY2025 auditor approved: 6.77M for, 42.2K against.
- Amendment to increase authorized common shares to 640M approved: 6.27M for, 548.9K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000121390025122240/0001213900-25-122240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000121390025122240/ea0269797-8k_therap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-122240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer